Clinical trial Recruiting at 1 site Interventional

Finding genetic causes of cleft lip and palate using whole exome sequencing

Official title: Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC

Run by Centre Hospitalier Universitaire, Amiens · NCT03065686 · Data updated 2026-11-12

This project will try to find genetic changes that cause non‑syndromic cleft lip and/or palate by sequencing the protein‑coding parts of DNA in patients seen at the Amiens center.

Quick facts

Study typeInterventional
SexAll
Enrollment30 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedNovember 30, 2016
Main results expectedNovember 30, 2027
Study endsNovember 30, 2027
Registry record updatedMay 13, 2026
Trial IDNCT03065686 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with non‑syndromic cleft lip and/or palate of unknown cause who are followed at CHU Amiens Picardie and who hold national health insurance.

Probably not a fit

Patients with a known genetic cause of their cleft (including IRF6 mutations), those with syndromic clefts, and individuals for whom no causative variant is identified are unlikely to gain direct clinical benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will perform whole exome sequencing (WES) on precisely phenotyped patients with non‑syndromic cleft lip and/or palate who are followed at the CHU Amiens Picardie multidisciplinary center. Eligible participants are those with NSCL/P of unknown cause who hold national health insurance, while cases with a known genetic cause or an IRF6 mutation are excluded. The project searches for rare or novel coding variants that may explain individual cases or reveal new disease genes, building on prior WES successes in craniofacial syndromes. Candidate variants will be interpreted alongside clinical phenotype and existing gene pathway knowledge to prioritize findings for follow‑up.

Why it matters

Potential benefit: If successful, the work could identify genetic causes for some patients, improving diagnosis, genetic counseling, and guiding future research.

How similar studies have gone: Whole exome sequencing has successfully identified causal genes in several craniofacial syndromes (for example Freeman‑Sheldon and Miller syndromes) and has been applied in cleft research, though non‑syndromic clefting remains genetically heterogeneous and many cases remain unexplained.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject with a NSCL/P or CL/P of unknown etiology,
* national health care insurance holders

Exclusion Criteria:

* Subject with a CL/P of known etiology,
* Subject with a NSCL/P and an IRF6 mutation

Where it's running

  • CHU Amiens Picardie
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.